Purine- and Nucleotide-mediated Relaxation of Rabbit Thoracic Aorta: Common and Different Sites of Action
- 1 May 1994
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 46 (5) , 337-341
- https://doi.org/10.1111/j.2042-7158.1994.tb03808.x
Abstract
The mechanisms of the relaxant effect of purines and pyrimidines in New Zealand rabbit isolated aorta were investigated at endothelial and smooth muscle cell levels. Endothelium-mediated relaxation by ATP was only partially inhibited by the P2-purinoceptor antagonist suramin (0·1 Mm). The pyrimidine UTP produced vasodilation by acting at the endothelial level and relaxation was not antagonized by suramin (0·1 Mm). This effect was not mediated by P2 purinoceptors, indicating that UTP, like ATP to a certain extent, produces relaxation via an endothelium nucleotide (N) pyrimidinoceptor. ATP, ADP, AMP, adenosine, 5′-N-ethylcarboxamidoadenosine (NECA) and inosine were all active as relaxants on smooth muscle. The NECA relaxant effect was not antagonized by P1-purinoceptor antagonists 3,7-dimethyl-1-propargylxanthine (50 μm) or 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (5 μm), excluding a P1-mediated effect. P2-related activity was excluded because adenosine-mediated relaxation was not antagonized by suramin (0·1 Mm). UTP was ineffective as a relaxant at smooth muscle level, thus excluding the presence of muscular nucleotide (N) pyrimidinoceptor and suggesting a P3 purinoceptor. The rank order of potency of this muscle purinoceptor was NECA > adenosine > ATP ≅ ADP ≅ AMP ≅ inosine.Keywords
This publication has 13 references indexed in Scilit:
- The regulation of aortic endothelial cells by purines and pyrimidines involves co‐existing P2y‐purinoceptors and nucleotide receptors linked to phospholipase CBritish Journal of Pharmacology, 1993
- Pharmacological characterization of a new purinergic receptor site in rabbit aortaGeneral Pharmacology: The Vascular System, 1992
- P2 purinoceptor-mediated cyclic AMP accumulation in bovine vascular smooth muscle cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Further subclassification of ATP receptors based on agonist studiesTrends in Pharmacological Sciences, 1991
- Suramin antagonizes responses to P2‐purinoceptor agonists and purinergic nerve stimulation in the guinea‐pig urinary bladder and taenia coliBritish Journal of Pharmacology, 1990
- Stimulation of prostacyclin release from aortic smooth muscle cells by purine and pyrimidine nucleotidesEuropean Journal of Pharmacology, 1988
- Suramin: a reversible P2‐purinoceptor antagonist in the mouse vas deferensBritish Journal of Pharmacology, 1988
- 3,7-Dimethyl-1-propargylxanthine: A potent and selective in vivo antagonist of adenosine analogsLife Sciences, 1988
- Characteristics of the P2 purinoceptor that mediates prostacyclin production by pig aortic endothelial cellsEuropean Journal of Pharmacology, 1987
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984